Polysaccharide-K
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Polysaccharide-K, covering 2023-04-18 to 2023-04-18. Get the full timeline:
Most recent: Clinical Trial Update: Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy [Phase 1, Phase 2]